Table 3.
Results on the comparative acceptability of the interventions from the network and pairwise meta-analyses
| Combination | 0.76 (0.38 to 1.52) (N=1; I2=NA*) |
1.03 (0.40 to 2.65) (N=3, I2=0%) |
NA† |
| 0.75 (0.47 to 1.21) (N=17; I2=0%) |
Exercise | 1.40 (1.13 to 1.72) (N=3; I2=0%) |
0.84 (0.27 to 2.58) (N=3; I2=14%) |
| 0.99 (0.62 to 1.57) (N=17; I2=0%) |
1.31 (1.09 to 1.57) (N=17; I2=0%) |
Antidepressants | 0.97 (0.84 to 1.13) (N=11; I2=0%) |
| 0.97 (0.60 to 1.58) (N=17; I2=0%) |
1.29 (1.03 to 1.61) (N=17; I2=0%) |
0.98 (0.84 to 1.15) (N=17; I2=0%) |
Control |
Results of the network meta-analyses are presented in grey and results of the pairwise meta-analyses are presented in white. Estimates are displayed as column versus row for the network meta-analyses and row versus column for the pairwise meta-analyses. Results are expressed as risk ratios (RRs). RRs that are smaller than one indicate a superiority of the first treatment over the comparison treatment.
*No evidence on I2 is available as there was only one study for that comparison.
†No studies compared combination treatment versus no treatment.
N, number of studies in the comparison; NA, not available.